Literature DB >> 6160006

Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.

C Bordignon, R Avallone, G Peri, N Polentarutti, C Mangioni, A Mantovani.   

Abstract

Human cells of the monocyte-macrophage lineage were isolated by adherence from peripheral blood, peritoneal exudate, non-neoplastic ascites, benign ovarian cystic fluid and bronchoalveolar lavages. Cytolytic activity was measured as 3H-thymidine release from prelabelled mKSA TU5 tumour cells over 48-72 hr and cytostasis was evaluated in a 72-hr spectrophotometric assay. Mononuclear phagocytes from the various anatomical sites examined, except lung alveolar spaces, were significantly cytolytic and cytostatic on target cells. Unlike other cells of the monocyte-macrophage lineage, alveolar macrophages were not cytocidal, but significantly inhibited tumour cell proliferative capacity. Peripheral blood monocytes and peritoneal macrophages showed enhanced cytotoxicity in the presence of partially purified human fibroblast interferon or of lymphokine supernatants from mitogen-stimulated lymphocytes. In contrast, interferon did not affect the cytotoxic potential of alveolar macrophages, whereas lymphokines augmented their cytostatic activity and rendered them weakly cytolytic.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160006      PMCID: PMC1537006     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice.

Authors:  M S Meltzer
Journal:  Cell Immunol       Date:  1976-03-01       Impact factor: 4.868

2.  Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells.

Authors:  S Kit; T Kurimura; D R Dubbs
Journal:  Int J Cancer       Date:  1969-07-15       Impact factor: 7.396

3.  Endocytosis of red blood cells or haemoglobin by activated macrophages inhibits their tumoricidal effect.

Authors:  J B Weinberg; J B Hibbs
Journal:  Nature       Date:  1977-09-15       Impact factor: 49.962

4.  Rat macrophage-mediated toxicity to cancer cells; effect of endotoxins and endotoxin inhibitors contained in culture media.

Authors:  F Martin; M Martin; J F Jeannin; A Lagneau
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

5.  Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series.

Authors:  R M Schultz; N A Pavlidis; W A Stylos; M A Chirigos
Journal:  Science       Date:  1978-10-20       Impact factor: 47.728

6.  Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking.

Authors:  E T Cantrell; G A Warr; D L Busbee; R R Martin
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

7.  The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics.

Authors:  A B Cohen; M J Cline
Journal:  J Clin Invest       Date:  1971-07       Impact factor: 14.808

8.  Genetic role of rat macrophage cytotoxicity against tumor.

Authors:  G A Miller; J D Feldman
Journal:  Int J Cancer       Date:  1976-08-15       Impact factor: 7.396

9.  Macrophage-mediated natrual cytotoxicity against various target cells in vitro. I. Macrophages from diverse anatomical sites and different strains of rats and mice.

Authors:  R Keller
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

10.  Macrophage-mediated natural cytotoxicity against various target cells in vitro. II. Macrophages from rats of different ages.

Authors:  R Keller
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

View more
  7 in total

1.  Phenotypic differentiation patterns of the human monocyte/macrophage system.

Authors:  H Kreipe; H J Radzun; M R Parwaresch
Journal:  Histochem J       Date:  1986-08

Review 2.  Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.

Authors:  P G Holt
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

3.  Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid.

Authors:  E Vicenzi; A Biondi; C Bordignon; A Rambaldi; M B Donati; A Mantovani
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

4.  Natural cytotoxic activity in human lungs.

Authors:  C Bordignon; F Villa; A Vecchi; R Giavazzi; M Introna; R Avallone; A Mantovani
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

5.  Phagocytic activity of alveolar macrophages in patients with bronchogenic carcinoma.

Authors:  J D Gangemi; G N Olsen; C Fechter; J A Hightower; C T Bauguess; L Krech
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

7.  Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.